Literature DB >> 23208079

Enhancement of antigen-specific immunoglobulin G responses by anti-CD48.

Dorothy Yuan1, Yuhong Guo, Suwannee Thet.   

Abstract

CD48 is a glycosylphosphatidylinositol-anchored protein expressed ubiquitously on many cell types. Despite the poor ability to signal on its own, CD48 can activate cells via interaction with its counter receptors CD2 and CD244 as well as influence the function of other cell surface molecules by costimulatory activities. We show, herein, that injection of anti-CD48 antibodies into mice can augment the antibody response to a T-independent antigen, NP-Ficoll, that is representative of antigenic determinants expressed on the surface of various pathogens, such as Streptococcus pneumoniae. In C57BL/6 mice, enhancement of the response is dependent on natural killer (NK) cells as well as on the presence of CD2 and CD244, ligands for CD48, suggesting a requirement for direct interaction between NK and B cells. Interestingly, in this case, despite a similar augmentation by anti-CD48 in BALB/C mice, the response is independent of NK or T cells, suggesting that help for this response can be derived from other innate cell types. These results provide a pathway by which CD48, when appropriately activated, can influence the course of an antigen-specific antibody response via the innate system.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208079      PMCID: PMC6741465          DOI: 10.1159/000345121

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  42 in total

Review 1.  T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens.

Authors:  A Jeurissen; J L Ceuppens; X Bossuyt
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.

Authors:  T von der Weid; A M Beebe; D C Roopenian; R L Coffman
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

3.  CD48 delivers an accessory signal for CD40-mediated activation of human B cells.

Authors:  E N Klyushnenkova; L Li; R J Armitage; Y S Choi
Journal:  Cell Immunol       Date:  1996-11-25       Impact factor: 4.868

4.  Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity.

Authors:  Daniel R Brown; Silvia Calpe; Marton Keszei; Ninghai Wang; Shannon McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

Review 5.  Natural killer cell activation secondary to innate pattern sensing.

Authors:  Tsukasa Seya; Jun Kasamatsu; Masahiro Azuma; Hiroaki Shime; Misako Matsumoto
Journal:  J Innate Immun       Date:  2011-03-29       Impact factor: 7.349

6.  Mechanism of induction of NK activation by 2B4 (CD244) via its cognate ligand.

Authors:  Suwan Kumar Sinha; Ning Gao; Yuhong Guo; Dorothy Yuan
Journal:  J Immunol       Date:  2010-09-29       Impact factor: 5.422

7.  Natural killer cells induce activated murine B cells to secrete Ig.

Authors:  C M Snapper; H Yamaguchi; M A Moorman; R Sneed; D Smoot; J J Mond
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

8.  2B4 inhibits NK-cell fratricide.

Authors:  Ruth T Taniguchi; Dustin Guzior; Vinay Kumar
Journal:  Blood       Date:  2007-05-30       Impact factor: 22.113

9.  Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo.

Authors:  K D Chavin; L Qin; J Lin; J Woodward; P Baliga; K Kato; H Yagita; J S Bromberg
Journal:  Int Immunol       Date:  1994-05       Impact factor: 4.823

10.  2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells.

Authors:  Kyung-Mi Lee; Megan E McNerney; Susan E Stepp; Porunelloor A Mathew; John D Schatzle; Michael Bennett; Vinay Kumar
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  1 in total

Review 1.  Roles of CD48 in regulating immunity and tolerance.

Authors:  Shannon L McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  Clin Immunol       Date:  2016-01-18       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.